Doctor profile · Federal record
Dr. Catherine Quinn, M.D.
Hematology & Oncology Physician (CMS: Medical Oncology) · Oceanside, CA
- NPI 1427403641
- Accepts Medicare
- MIPS 92.4 / 100 · 2023
- 10 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3617 Vista Way
Oceanside, CA 920564522
(760) 758-5770
fax (760) 721-8597
Credentials & registration
- NPI registered
- April 2016 — 10 yrs on file
- Profile last updated
- July 22, 2024
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A162757
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427403641. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,062
Distinct HCPCS
10
Medicare allowed
$103,421
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 2,400 | 20 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,010 | 29 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 888 | 22 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 168 | 74 | $8 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 164 | 48 | $150 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 96 | 29 | $33 | |
96372 |
Injection of drug or substance under skin or into muscle | 86 | 32 | $15 | |
96375 |
Injection of additional new drug or substance into vein | 80 | 16 | $17 | |
J1200 |
Injection, diphenhydramine hcl, up to 50 mg | 45 | 15 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 40 | 17 | $137 |
In context: peer comparison
Among 3 peers in Oceanside Hematology & Oncology Physician, average services per provider: 792. This provider delivers 6.4× the peer median.Open Payments
Industry payments received
All-time total
$1,615
Transactions
41
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 4 | $330.71 | |
| Pfizer INC. | 8 | $209.93 | |
| Daiichi Sankyo INC. | 5 | $159.49 | |
| Novartis Pharmaceuticals Corporation | 5 | $129.05 | |
| Janssen Biotech, INC. | 4 | $94.22 | |
| SpringWorks Therapeutics, INC. | 2 | $81.95 | |
| Sobi, INC | 2 | $63.31 | |
| BeiGene USA, INC. | 2 | $55.33 | |
| Eisai INC. | 2 | $50.52 | |
| Incyte Corporation | 2 | $46.42 | |
| Genzyme Corporation | 1 | $38.60 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $35.50 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $31.84 | |
| Alexion Pharmaceuticals, INC. | 1 | $30.97 | |
| Deciphera Pharmaceuticals INC. | 1 | $28.82 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
89
Patients
35
Total drug cost
$2,176
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mirtazapine | Generic | 23 | 0 | $610 |
| Prochlorperazine Maleate | Generic | 15 | 12 | $228 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 13 | 11 | $211 |
| Midodrine Hcl | Generic | 13 | 0 | $556 |
| Ondansetron Odt (Ondansetron) | Brand | 13 | 12 | $271 |
| Acyclovir | Generic | 12 | 0 | $301 |
Frequently asked questions
What is Dr. Catherine Quinn's medical specialty?
Dr. Catherine Quinn practices Hematology & Oncology Physician in Oceanside, CA.
Where does Dr. Catherine Quinn practice?
Dr. Catherine Quinn practices at 3617 Vista Way, Oceanside, CA 920564522. Office phone: 7607585770.
What is Dr. Catherine Quinn's NPI?
Dr. Catherine Quinn's National Provider Identifier (NPI) is 1427403641, issued by NPPES.
Does Dr. Catherine Quinn accept Medicare assignment?
Yes. Dr. Catherine Quinn accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Catherine Quinn commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Injection, ondansetron hydrochloride, per 1 mg (HCPCS J2405). Source: CMS Medicare Physician & Other Practitioners file.